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Receptor-mediated internalization to the endoplasmic reticulum (ER) and subsequent retro-translocation to the cytosol are
essential sequential processes required for the productive intoxication of susceptible mammalian cells by Shiga-like
toxin-1 (SLTx). Recently, it has been proposed that the observed association of certain ER-directed toxins and viruses with
detergent-resistant membranes (DRM) may provide a general mechanism for their retrograde transport to endoplasmic
reticulum (ER). Here, we show that DRM recruitment of SLTx bound to its globotriosylceramide (Gb3) receptor is
mediated by the availability of other glycosphingolipids. Reduction in glucosylceramide (GlcCer) levels led to complete
protection against SLTx and a reduced cell surface association of bound toxin with DRM. This reduction still allowed
efficient binding and transport of the toxin to the ER. However, toxin sequestration within DRM of the ER was abolished
under reduced GlcCer conditions, suggesting that an association of toxin with lipid microdomains or rafts in the ER
(where these are defined by detergent insolubility) is essential for a later step leading to or involving retro-translocation
of SLTx across the ER membrane. In support of this, we show that a number of ER residents, proteins intimately involved
in the process of ER dislocation of misfolded proteins, are present in DRM.
INTRODUCTION
Shiga-like toxin 1 (SLTx) is a potent ribosome-inactivating
protein produced by certain enterohemorrhagic strains of
Escherichia coli and is virtually identical to Shigella toxin
(STx). It consists of a single A-chain possessing rRNA-spe-
cific N-glycosidase activity (Endo et al., 1988) and five non-
covalently associated B-subunits (SLTxB) that are responsi-
ble for binding and uptake into target cells (Pudymaitis et al.,
1991; Sandvig et al., 1994; Ling et al., 1998). To inactivate
ribosomes, SLTx (or at least the enzymatic A subunit) must
traverse an internal membrane, thought to be the endoplas-
mic reticulum (ER) membrane. This is also the retro-trans-
location site for internalized STx, cholera toxin (CTx), ricin,
E. coli heat-labile enterotoxin, pertussis toxin, and Pseudomo-
nas exotoxin A (Lencer and Tsai, 2003; Lord et al., 2003;
Roberts and Smith, 2004; Sandvig et al., 2004) whose sub-
strates also reside within the cytosol. Although the details of
toxin translocation remain sketchy, it is thought that these
proteins can co-opt ER components and exploit the ER retro-
translocation machinery normally used in the perception
and dislocation of newly made but misfolded or orphan
polypeptides in readiness for their destruction by protea-
somes. To be effective, however, the toxins must somehow
uncouple from downstream cytosolic steps to avoid being
completely degraded (Hazes and Read, 1997; Deeks et al.,
2002; Rodighiero et al., 2002).
To reach the ER, SLTx must first bind, through the B
subunits, to its globotriaosylceramide (Gb3/CD77) receptors
at the plasma membrane (Jacewicz et al., 1986). Internaliza-
tion of the toxin is known to proceed via the endosomal
system and the trans-Golgi network in a process that by-
passes late endosomes (Mallard et al., 1998; Mallard et al.,
2002). This is followed by coatomer protein 1-independent
transport through the Golgi to the ER (Girod et al., 1999;
White et al., 1999). Although the extent and identity of
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cellular proteins trafficking from the plasma membrane to
the early Golgi and ER are not fully known, the retrograde
trafficking of some glycosphingolipids (GSL) to the Golgi
has been recognized (Puri et al., 2001). It has recently been
proposed that the retrograde routing of GSL-binding toxins
to the ER involves association of the toxin/GSL complex
with lipid microdomains (Fujinaga et al., 2003), often re-
ferred to as lipid rafts that are enriched in certain GSL,
specific proteins, and cholesterol (Simons and Ikonen, 1997;
Brown and London, 2000). These are isolated on the basis of
detergent resistance, and the resulting detergent-resistant
membranes (DRM) are interpreted to represent lipid mi-
crodomains in the original membrane. Indeed, there is a
strong correlation between the ER routing of the B-chain of
the related STx and its association with DRM in toxin-
sensitive HeLa cells. By contrast, in a macrophage cell line in
which DRM association of STx B was not observed, the toxin
was directed to lysosomes, and the cells survived (Falgui-
eres et al., 2001).
Recently, it has been shown that the normal retrograde
transport of an internalized GSL, lactosylceramide (LacCer),
to the Golgi can be altered dramatically by chemical modu-
lation of endogenous glucosylceramide (GlcCer) levels (Sil-
lence et al., 2002). Indeed, treatment of RAW macrophages
with the imino sugar N-butyldeoxygalactonojirimycin (NB-
DGJ), a specific inhibitor of ceramide glucosyltransferase
(Andersson et al., 2000), resulted in lysosomal targeting of
LacCer (Sillence et al., 2002). A question arising from this is
whether modulation of cellular GlcCer levels also affects the
trafficking and cytotoxicity of SLTx.
In the present study, we have investigated the effect of
NB-DGJ on the intracellular uptake and cytotoxicity of SLTx.
We show that NB-DGJ completely protected both Vero and
HeLa cells from SLTx intoxication. Furthermore, we have
shown that the affinity of toxin for DRM was modulated by
the presence of GlcCer, such that its partitioning into DRM
was lowered at the plasma membrane and abolished within
the ER upon treatment with the inhibitor. Membrane bind-
ing and subsequent retrograde transport of toxin to the ER
was unaffected by NB-DGJ treatment. This result led us to
propose that SLTx requires an association with lipid rafts
within the ER membrane for efficient retro-translocation to
the cytosol. In support of this, we have demonstrated that
certain ER-resident proteins, which are intimately involved
in the retro-translocation process, are themselves seques-
tered into DRM.
MATERIALS AND METHODS
Sources
NB-DGJ was purchased from Calbiochem (San Diego, CA). Antibodies were
kindly provided against calnexin, ribophorins, and Sec61 by Steve High
(University of Manchester, Manchester, United Kingdom), Derlin-1 and VIMP
by Tom Rapoport (Harvard University, Cambridge, MA), and SLTx by Arthur
Donohue-Rolfe (Tufts University, Boston, MA). Antibody against protein
disulfide isomerase (PDI) was purchased from Stressgen Biotechnologies
(Victoria, British Columbia, Canada), and antibody against transferrin recep-
tor was purchased from Zymed (South San Francisco, CA). Radioisotopes
were from GE Healthcare (Little Chalfont, Buckinghamshire, United King-
dom). Cross-linkers and IODO-BEADS iodination reagent were obtained
from Pierce Chemical (Cheshire, United Kingdom). Cyclosporin A came from
Sigma (Poole, Dorset, United Kingdom). Glucosylsphingosine came from
Matreya (Universal Biologicals, Stroud, United Kingdom).
Cell Lines
All cell lines were maintained in RPMI 1640 medium containing 2 mM
l-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin (Invitrogen, Carls-
bad, CA), and 5% fetal calf serum (Labtech, Ringmer, United Kingdom).
Cytotoxicity Assays
Cells were seeded at 2.5 104 cells/well into flat-bottomed 96-well plates and
grown overnight. Cells were then overlaid with medium containing appro-
priate concentrations of SLTx for 4 h. Remaining cellular protein synthesis
after toxin treatment was determined as the incorporation of [35S]methionine
into total protein as described previously (Deeks et al., 2002; Smith et al., 2003)
Biochemistry, Binding, and Internalization Analysis
Protein iodination, Scatchard analysis, and glycosylation analysis were per-
formed as described previously (Johannes et al., 1997; Mallard et al., 1998;
Spooner et al., 2004).
Preparation and Analysis of DRM from HeLa and
L3/bcl-2 Cells
DRM were prepared as published previously (Benting et al., 1999; Falguieres
et al., 2001). Briefly, the required amount of cells for 300 g of total protein
was washed once with phosphate-buffered saline (PBS) and resuspended in
0.2 ml of 2 TNE (1 TNE: 25 mM Tris-HCl ,pH 7.4, 150 mM NaCl, 2.5 mM
EDTA, and a mixture of protease inhibitors containing phenylmethylsulfonyl
fluoride, leupeptin, chymostatin, pepstatin, antipain, and aprotinin). All steps
were performed on ice. Cells were lysed by passage through a ball homoge-
nizer (20 times). The postnuclear supernatant (PNS) was collected after a spin
at 4°C, 3000  g for 10 min; the 0.2-ml volume was added to an equal volume
of 2% Triton X-100 (Tx-100), and the mixture was incubated on ice for 30 min.
OptiPrep (Sigma) was added to a final concentration of 40%. The solutions
were overlaid with 2.3 and 0.8 ml of 30 and 5% OptiPrep in TNE, respectively,
and spun at 4°C, 28,000 rpm, for 4 h (SW41 rotor; Beckman Coulter, Fullerton,
CA). The gradient was fractionated manually from the top. DRM were found
at the 5/30% interface. To analyze the fractions, Western blotting and dot blot
analysis were performed according to standard procedures.
Glycolipid Extraction from L3/bcl-2 Cells and Toxin
Overlay
Lipid extraction was carried out according to the published method (Bligh
and Dyer, 1959), with the previously described modifications (Falguieres et al.,
2001), as described above. After DRM gradient fractionation, the isolated
neutral glycolipids were spotted on high-performance thin layer chromatog-
raphy (TLC) plates (Merck, Darmstadt, Germany) and separated with chlo-
roform/methanol/water (65:25:4). Dried plates were soaked in 0.1% poly-
isobutylmethacrylate in hexane and floated for 1 h in blocking solution,
followed by incubation with 20 nM SLTxB, primary polyclonal anti-SLTxB,
and secondary horseradish peroxidase, or alkaline phosphatase-coupled anti-
rabbit antibodies. Reactive bands were revealed with the use of enhanced
chemifluorescence (GE Healthcare) and PhosphorImager.
Isolation of DRM for Lipid Analysis
DRM were purified as published previously (Lisanti et al., 1995). Briefly,
tissues were homogenized with 10 strokes of a Dounce homogenizer in PBS.
The PNS was collected after a spin at 4°C, 3000 g for 10 min, the volume was
added to an equal volume of 1% Tx-100, and the mixture was incubated on ice
for 30 min. The solution made up to 40% sucrose and transferred to a
Beckman Ultraclear 14  89-mm tube on ice, and a discontinuous gradient of
5 ml of 30% sucrose and 3 ml of 5% sucrose was layered on top. Samples were
ultracentrifuged in a SW41 rotor at 100,000  g for 16 h at 4°C, and 2-ml
fractions were manually collected.
Purification and Preparation of GSL for HPLC
GlcCer was purified on silicic acid columns, washed with 2 ml of CHCl3 and
2 ml of CHCl3/MeOH (98:2). GlcCer was eluted with 2 ml of CHCl3/MeOH
(97:3), 2 ml of CHCl3/MeOH (96:4), 2 ml of CHCl3/MeOH (95:5), and 2 ml of
CHCl3/MeOH (94:6), and dried down and resuspended in 15 l of 50 mM
sodium acetate buffer, pH 5, with 0.1% Triton and 0.25% taurocholate. Then,
0.4 U of purified glucocerebrosidase (cerezyme) was added and incubated at
37°C for 18 h. Samples were derivatized using the same method as for the
GSL. Other GSL were extracted by the addition of 3.2 vol of CHCl3/MeOH
(1:2.2) for 10 min at room temperature, and the phases were split by the
addition of 1 vol of CHCl3 and 1 vol of H2O (Bligh and Dyer, 1959). This quick
extraction procedure gave similar recoveries of GSL to other commonly used
methods of lipid extraction (van Echten et al., 1990; Miller-Podraza et al., 1992).
Upper phase GSL were then recovered by SePak C18 columns (Sillence et al.,
2000). Briefly, C18 SepPak columns (Waters, Milford, MA) were washed with
1 ml of MeOH and 1 ml of water. The CHCl3 phase was dried down and
loaded in 50 l of CHCl3/MeOH (1:3). The corresponding aqueous phase was
loaded onto the columns and washed with 1 ml of water five times. GSL were
then eluted with 1 ml of CHCl3/MeOH (1:3) five times and 1 ml of MeOH,
and the samples were dried under nitrogen. At this point, the cholesterol and
GSLs were quantified as described below. For mass spectrometry, the samples
were saponified by the addition of 1 ml of CHCl3 and 1 ml of 0.2 M NaOH in
methanol and incubated overnight at 37°C and further purified by silicic acid
chromatography (Vance and Sweeley, 1967). Silicic acid columns were pre-
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equilibrated in CHCl3, and the samples were loaded onto the column and
washed with 5 ml of CHCl3. Neutral GSL were eluted with 6 ml of acetone/
MeOH (9:1). Gangliosides were eluted with 6 ml of CHCl3/MeOH (1:3), and
the eluates were dried under nitrogen. The samples were resuspended with
1  50 l and then 1  100 l of CHCl3/MeOH (1:2.2) and transferred to a
1.5-ml tube. The samples were dried down in a SpeedVac and resuspended in
20 l of MeOH.
Quantitation of GSL Derivatives by High-Performance
Liquid Chromatography (HPLC)
GSL were analyzed according to Neville et al. (2004). To dried lipid extracts,
10 l of incubation buffer (1 mg/ml sodium cholate in 50 mM sodium acetate,
pH 5.0) was added. After vigorous vortexing and spinning in a benchtop
picofuge, 10 l of 50 mU/10 l ceramide glycanase (E.C. 3.2.1.123; Calbio-
chem) in incubation buffer was added to cleave the glycans. Glucosylceram-
ide is partially digested because of the specificity of the glycanase (Wing et al.,
2001). After this period, 10 l of water was added to each enzyme digest
followed by 80 l of anthranilic acid and sodium cyanoborohydride to each
digest and incubated in the 80°C oven for 1 h. Derivatized oligosaccharides
were then purified on DPA-6S (Supelco, Bellefonte, PA) columns preequili-
brated with 2  1 ml CH3CN. One milliliter of 97:3 CH3CN/H2O was added
to each sample and vortexed before loading the samples onto the columns.
Columns were washed with 1 ml of 99:1 CH3CN/H2O four times and then
with 0.5 ml of 97:3 CH3CN/H2O, and the derivatized oligosaccharides were
eluted with 0.6 ml water two times into screw-cap Eppendorfs and stored at
4°C in the dark until ready for normal phase-HPLC.
Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) mass spectrometry was
performed as described previously (Hunnam et al., 2001). Briefly, a mixture of
the sample (1 l; 100 pmol) and matrix (1 l of a saturated solution of
2,5-dihydroxybenzoic acid in acetonitrile) was crystallized on the MALDI
target. Positive ion reflectron MALDI spectra were obtained with a Micro-
mass TOFSpec 2E mass spectrometer equipped with delayed extraction (Mi-
cromass UK, Wythenshawe, Manchester, United Kingdom). The instrument
was operated as follows: accelerating voltage, 20 kV; pulse voltage, 3200 V;
and laser repetition rate of 10 Hz and calibrated externally with hydrolyzed
dextran sugars.
Immunofluorescence Methods
HeLa cells were fixed at room temperature for 20 min in 3% paraformaldehyde,
quenched with 30 mM glycine, permeabilized with 0.1% Tx-100, incubated with
the indicated primary or secondary antibodies, mounted, and viewed by confocal
microscopy (Leica Microsystems, Mannheim, Germany). For Tx-100 extraction
on living cells, the cells were put on ice, washed once with PBS containing 1 mM
MgCl2 and 0.5 mM CaCl2, and incubated for 1 min in 1% Triton/PIPES buffer (80
mM PIPES, pH 6.8, 5 mM EGTA, and 1 mM MgCl2). The buffer was then
removed and 3% paraformaldehyde was added for 15 min at room temperature
as described previously (Falguieres et al., 2001).
RESULTS
The Toxicity of SLTx Is Completely Abrogated upon
Treatment with NB-DGJ, an Inhibitor of
Glycosphingolipid Biosynthesis
For a productive intoxication of susceptible mammalian
cells, SLTx is required to bind its GSL receptor, Gb3, for
uptake and delivery to the ER lumen from where the toxin
is dislocated to the cytosol to inactivate ribosomes (Sandvig
and van Deurs, 2002; Smith et al., 2004). Because treatment of
fibroblasts and macrophages with NB-DGJ redirects endo-
cytosed GSL (LacCer), away from the Golgi and into lyso-
somes (Sillence et al., 2002), we investigated whether NB-
DGJ could similarly alter the cell entry and therefore the
potency of SLTx. The cytotoxic effect of SLTx on cellular
protein biosynthesis was measured by incubating cells with
increasing concentrations of the toxin (Figure 1). When HeLa
and Vero cells were pretreated with NB-DGJ for 16 h before
a 4-h toxin challenge in the continued presence of the drug,
cellular protein synthesis was unaffected (Figure 1, A and C).
Similar protection was seen with DL-1-phenyl-2-palmi-
toylamino-3-morpholino-1-propanol, a chemically unrelated
Figure 1. NB-DGJ protects both HeLa and
Vero cells from SLTx. HeLa (A and B) and
Vero (C and D) cells were pretreated with
either media (control, F) or 100 M NB-DGJ
(E) for either 16 h (A and C) or 2 h (B and D).
After pretreatment, cells were washed and
incubated with increasing concentrations of
SLTx for 4 h at 37°C. Incorporation of
[35S]methionine was used to determine re-
maining cellular protein synthesis, compared
with untreated cells. The means of three in-
dependent experiments are shown. SEs were
10%.
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inhibitor of glucosylceramide synthesis (our unpublished
data). A significant protection was also seen after a short 2-h
pretreatment with the drug (Figure 1, B and D). Because
HeLa cell sensitivity to SLTx could be modulated by NB-
DGJ in a time- and concentration-dependent manner (our
unpublished data), with maximal protection seen after 2 h
with 100 M NB-DGJ (Figure 1B), all subsequent experi-
ments were performed under these conditions.
Because NB-DGJ is an inhibitor of GSL biosynthesis, both
GSL composition and binding studies were performed with
SLTx after a 2-h pretreatment with 100 M NB-DGJ. Anal-
ysis of the GSL composition in HeLa cells treated with 100
M NB-DGJ (2 h) showed that the total levels of Gb3 re-
mained unaltered, whereas the levels of GlcCer decreased to
38% of control cell levels, with reductions also seen in the
levels of II3--N-acetylneuraminyllactosylceramide (GM3)
and neolactotetraglycosylceramide (nLc4) (Table 1). Consis-
tent with this, Scatchard analysis demonstrated that the
binding affinity and number of SLTx receptor sites (i.e., Gb3)
remained essentially unaltered compared with controls (Ta-
ble 2). Interestingly, the levels of LacCer, the next GSL to be
synthesized sequentially from GlcCer, remained unaltered
after NB-DGJ treatment (Table 1). Analysis of the Tx-100-
resistant fraction isolated from NB-DGJ-treated cells high-
lighted changes within the level of all the GSL examined,
with the exception of LacCer, with significant changes oc-
curring for GlcCer and Gb3, implying that inhibition of GSL
biosynthesis rapidly altered the composition of these lipids
in DRM. Cells remained sensitive to SLTx when NB-DGJ
was coadministered with the toxin; furthermore, NB-DGJ
pretreatment had no effect on the cytotoxicities of two other
ER-directed protein toxins, Pseudomonas exotoxin A and ri-
cin (our unpublished data). Together, these findings rule out
as explanations for the SLTx-resistance phenotype a lack of
surface receptors, a perturbation of the toxin uptake path-
ways, and, because of the identical catalytic mechanism of
SLTx and ricin (Furutani et al., 1992), a direct inhibitory effect
of the drug upon the SLTx active site.
Trafficking of SLTx to the ER Is Not Perturbed by
NB-DGJ Treatment
Productive intoxication with SLTx requires the initial bind-
ing of toxin to surface Gb3 molecules followed by retrograde
transport of the complex to the ER. The length of the Gb3
fatty acyl chain is important for efficient ER targeting of the
toxin, with the presence of the shorter chain (C16–C18)
isoforms being associated with enhanced cellular sensitivity
and ER targeting of SLTx (Sandvig et al., 1994; Arab and
Lingwood, 1998). We therefore examined the possibility that
NB-DGJ treatment was altering the availability of shorter
chain Gb3 isoforms, thereby disrupting transport to the ER.
However, mass spectrometric analysis of the chain lengths
of Gb3 isoforms isolated after NB-DGJ treatment showed no
significant difference compared with control cells (Table 3).
Because treatment with NB-DGJ is known to alter trafficking
of LacCer to the lysosomes in certain cell types (Sillence et
al., 2002), we next examined whether the intracellular rout-
ing of SLTx had been altered after NB-DGJ treatment. The
routing of toxin to the ER can be monitored and quantified
using a radiolabeled SLTx-B chain variant engineered to
contain a glycosylation sequence that becomes posttransla-
tionally core glycosylated upon arrival in the ER (Johannes
et al., 1997). Using such an approach, the amounts of core
glycosylated, radiolabeled SLTxB were identical in NB-DGJ-
treated HeLa cells and in control cells (Figure 2). The core-
glycosylated SLTxB moieties disappeared upon tunicamycin
treatment of the cells (Figure 2A), confirming that the pro-
teins detected had become glycosylated, a modification that
is only possible within the ER lumen. This clearly demon-
strated that SLTx transport to the ER is unaltered by NB-DGJ
treatment. It should be noted that this atypical, posttransla-
tional N-glycosylation of a protein entering the ER from the
Golgi is generally inefficient. The proportion of SLTx glyco-
Table 1. GSL composition in HeLa cells in the presence of NB-DGJ
Control
NB-DGJ
(2 h)
NB-DGJ
(16 h)
Total levels of GSL examineda
Gb3 1.00  0.40 1.00 0.30 0.50 0.10
GlcCer 2.60  0.10b 1.00  0.10b 0.60  0.10
LacCer 1.00  0.50c 0.60  0.20c 0.60  0.20
GM3 1.00  0.30 0.40 0.20 0.40 0.10
nLc4 0.20  0.06 0.10 0.05 0.10 0.04
Sialyl- nLc4 0.40  0.10 0.20 0.10 0.10 0.05
Tx-100-resistant levels of GSL examineda
Gb3 71  8d 37  9d 34  8
GlcCer 101  3e 51  2e 43  1
LacCer 39  2f 27  6f 27  5
GM3 35  2 10  1 10  1
nLc4 13  1 5  1 6  2
Sialyl- nLc4 10  1 6  1 4  1
a Picomoles per microgram of protein (SE); n  3–7.
b Extremely statistically significant, two-tailed p value  0.0001.
c Not statistically significant, two-tailed p value  0.4104.
d Statistically significant, two-tailed p value  0.0179.
e Extremely statistically significant, two-tailed p value  0.0001.
f Not statistically significant, two-tailed p value  0.1066.
Table 2. Binding of SLT-1 to HeLa cells
Kda (nM)
Gb3 binding
sites/cella
Control 81.1 26.6 13.1  6.6  106
NB-DGJb 62.7  24.5 11.9  5.0  106
a Determined using standard Scatchard analysis, n  3.
b HeLa cells pretreated with 100 M NBDGJ for 2 h at 37°C.
Table 3. Effect of NB-DGJ on the fatty acid composition of DRM
and non-DRM-associated Gb3
Gb3 species
Control NB-DGJ (2 h)
DRMa Soluble DRM Soluble
C24 42  1b 43  2 46  1 46  1
C24:1 8  2 7  2 5  1 3  2
C22 35  2 35  1 36  1 31  3
C18 4  1 4  1 4  1 4  1
C16 6  2 9  3 7  2 8  3
a DRM were isolated in cold Tx-100 from confluent monolayers (5
mg of protein).
b Gb3 species expressed as a mean percentage of total fatty acids 
SE, n  3–4 experiments.
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sylated in this way is on a par with previously reported
levels (Falguieres et al., 2001).
SLTx Can Be Associated with DRM in the ER Membrane
Because SLTx was still efficiently transported to the ER after
NB-DGJ treatment, we hypothesized that the mechanism
through which protection against the toxin was observed
may reside at the level of the ER. ER targeting of SLTx has
been correlated to an association with DRM at the plasma
membrane (Falguieres et al., 2001; Hoey et al., 2003). This
association persisted through to the ER, as shown by the
presence of ER-glycosylated SLTxB-KDEL in DRM (Falgui-
eres et al., 2001). It was therefore pertinent to test whether
SLTx persisted within DRM in the ER membrane after NB-
DGJ treatment. To examine this, iodinated “glycosylatable”
SLTxB was bound and internalized into HeLa cells for 4 h
after pretreatment with NB-DGJ. DRM association of ER-
localized (i.e., glycosylated) SLTxB was investigated using
the technique of buoyant density-gradient centrifugation
after extraction in the presence of cold Tx-100, a widely
accepted method for the isolation of DRM (Brown and Lon-
don, 2000; Simons and Toomre, 2000). Gradient fractions
were isolated and analyzed for the presence of the ER-
localized glycosylated SLTxB. Our data confirmed the pre-
vious observation (Falguieres et al., 2001) that in control
cells, a proportion of the ER-glycosylated SLTxB was local-
ized to DRM (Figure 3A, asterisk, top). This result was
supported visually. After 4 h of toxin treatment, a significant
amount of fluorescently labeled SLTx could be seen within
the reticular and perinuclear ER structures, along with a
proportion of the ER marker, Sec61 (Figure 3B, top row).
After treatment with cold 1% Tx-100, a fraction of the SLTx
and Sec61 was extracted, but a significant proportion re-
mained, and the two proteins displayed a degree of overlap
around the perinuclear and peripheral ER area (Figure 3B,
second row). This suggested that they had a specific distri-
bution within the ER, possibly reflecting their presence in
lipid microdomains in the ER membrane before detergent
treatment. On treating cells with NB-DGJ followed by inter-
nalization of iodinated SLTxB, no glycosylated SLTxB was
detectable within the DRM fraction (Figure 3A, second
panel, lane 2). Nevertheless, the same proportion of SLTxB
became glycosylated as in the untreated cells (Figure 3A,
top). Transport to the ER after NB-DGJ treatment was also
supported by the localization of SLTx within perinuclear
reticular structures (Figure 3B, third row). However, after
cold Tx-100 extraction, SLTx was completely solubilized
from NB-DGJ-treated cells, whereas an appreciable propor-
tion of the Sec61 remained (Figure 3B, fourth row). To-
gether, these data revealed that a proportion of SLTx is
normally found with DRM within the ER and that this
association was abolished upon treatment with NB-DGJ.
NB-DGJ Alters the Recruitment or Association of SLTx
into DRM
Because NB-DGJ treatment abolished DRM association of
SLTx within the ER membrane, we next investigated DRM
Figure 2. Transport of SLTx-B to the ER occurs in cells treated with
NB-DGJ. Transport to the ER was examined by glycosylation anal-
ysis. Iodinated SLTx-B (50 nM) was internalized into control HeLa
cells or NB-DGJ (100 M; 2 h)-treated HeLa cells for 4 h. Cells were
lysed, and the lysates were analyzed by gel electrophoresis (A).
Tunicamycin (Tm) treatment of cells to inhibit N-glycosylation was
performed before toxin internalization. G0 and G1 indicate the un-
modified and the ER glycosylation product, respectively. The lower
band (*) is a proteolytic cleavage product. (B) Quantitation of three
independent experiments.
Figure 3. ER-localized glycosylated SLTx-B is present in DRM, an
association that is perturbed by NB-DGJ. (A) Iodinated SLTx-B was
bound and internalized into either control or NB-DGJ (100 M;
2 h)-treated HeLa cells for 4 h. Cells were then washed and me-
chanically lysed, with the PNS being extracted in 1% Tx-100 buffer.
DRM were floated in OptiPrep step gradients. The gradients were
fractionated, and the presence of the SLTx-B was determined by gel
electrophoresis. G0 and G1 (*) indicate the unmodified and the
ER-located glycosylation product, respectively. Quantitation of G1
(% of total) was determined from three independent experiments.
Gradients were also analyzed by dot-blot for GM1 (DRM marker)
and by gel electrophoresis and blotting for a non-DRM marker, the
transferrin receptor (TnF-R). (B) Cy2-coupled SLTx-B was bound to
the plasma membrane of control or NB-DGJ (100 M; 2 h)-treated
HeLa cells on ice and washed and shifted to 37°C for 4 h. Cells were
then washed and placed on ice, incubated (Tx-100) or not for 1 min
in cold 1% Tx-100-containing buffer, and then fixed and permeabil-
ized. Cells were then probed with a primary Sec61 antibody,
washed, and incubated with an Alexa 633-coupled secondary anti-
body, mounted, and viewed by confocal microscopy. Bar, 5 m.
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association of SLTx bound at the cell surface at 4°C. In
agreement with a previous study (Falguieres et al., 2001),
40% of the bound SLTx was sequestered within the iso-
lated GM1-containing DRM fraction of untreated cells as
determined using resistance to extraction in cold 1% Tx-100
and subsequent flotation based on buoyant density (Figure
4A). Interestingly, the level of SLTx found with the DRM
fraction was reduced from 40 to 22% after treatment of cells
with the drug (Figure 4B). This correlated well with the
halving of DRM-sequestered Gb3 after NB-DGJ treatment
(Table 1). However, although there was less toxin associated
with isolated DRM, enough SLTx remained within such
lipid microdomains in the plasma membrane in vivo to
permit transport to the ER. Interestingly, the DRM associa-
tion of SLTxB observed in macrophages, where toxin is
routed to the lysosome, was 2% of the total toxin bound
(Falguieres et al., 2001).
If the recruitment of Gb3 into lipid rafts occurs upon toxin
binding in HeLa cells, as has been suggested (Falguie`res and
Johannes, unpublished data), then a prediction arising from
this is that NB-DGJ treatment should have little or no effect
on Gb3 molecules already associated with lipid rafts before
toxin binding and therefore have correspondingly little or
no effect on SLTx cytotoxicity. Indeed, the cytotoxicity ob-
served with SLTx was not significantly altered after either a
2-h (Figure 5A) or 16-h (our unpublished data) NB-DGJ
pretreatment of a Burkitt’s lymphoma derived-line, L3/
bcl-2, in which a high level of Gb3 is found associated at all
times within the isolated DRM fraction (Figure 5B). This
implied that the binding of ligand to Gb3 did not alter its
DRM association in this cell type. The amount of Gb3 found
with DRM was not affected after drug treatment (our un-
published data). Indeed, analysis of L3/bcl-2 cells shows
that after a 2-h treatment with NB-DGJ, there was no signif-
icant effect on the levels of the GSL examined (Table 4).
However, after 16 h the level of GlcCer was decreased by
50% showing that L3/bcl-2 cells were nevertheless sensi-
tive to the drug. Furthermore, there was no change in the
level of SLTx found in the DRM fraction after NB-DGJ
treatment compared with control cells (Figure 5, C and D).
This was in marked contrast to the situation seen in HeLa
cells (Figure 4). These findings support our prediction that
NB-DGJ perturbs the recruitment to and/or the affinity of
SLTx/Gb3 complexes to associate with lipid rafts at the cell
surface.
DRM Association of SLTx/Gb3 Can Be Influenced by the
Levels of Glucosylceramide
Because NB-DGJ specifically inhibits ceramide glucosyl-
transferase (Platt et al., 1994), an enzyme that catalyzes the
first step in GSL biosynthesis located in the cis-Golgi, it was
not immediately obvious how this drug was able to perturb
recruitment of SLTx into lipid rafts at the plasma membrane.
However, this phenomenon might be explained by the levels
of available GlcCer in the cell. NB-DGJ inhibits synthesis of
GlcCer from ceramide, thus reducing production of GSL
(Platt et al., 1994; Andersson et al., 2000). Indeed, after treat-
ment with NB-DGJ the DRM-associated GlcCer was reduced
by 50% in a 2-h period in HeLa cells (Table 1), whereas the
level of LacCer in DRM—the GSL directly synthesized from
GlcCer—was not significantly changed (Table 1). We rea-
soned that the level of GlcCer may therefore influence the
affinity of surface-bound SLTx for DRM. To address this, we
introduced exogenous Gb3 into GM95 cells that have very
low levels of endogenous GSL and that completely lack Gb3
(Ichikawa et al., 1994). After overnight incubation, 20% of
the Gb3 became sequestered into the DRM fraction after
toxin binding (Figure 6A). When GM95 cells were coincu-
bated with Gb3 and glucosylsphingosine (GlcSph), a com-
pound that can be acylated to increase the concentration of
cellular GlcCer (Farrer and Dawson, 1990), the amount of
toxin-bound Gb3 in DRM increased to 50% (Figure 6A).
The increased population of the complex within DRM did
not arise from a conversion of GlcCer to Gb3, because GM95
cells lack Gb3 synthase (Ichikawa et al., 1994). In accordance
with this, an increase in the total level of Gb3 was not
observed (Figure 6B). By contrast, cellular II3--N-acetyl-
neuraminyllactosylceramide (GM3) levels did increase after
GlcSph treatment (Figure 6B), showing that the additional
GlcCer generated from the added GlcSph had allowed an
increase in the levels of other GSL. These data suggest that
the levels of GlcCer can influence, directly or indirectly, the
amount of bound toxin that becomes recruited to DRM.
We then modulated the activity of P-glycoprotein
(MDR-1) because it is known that overexpression of MDR-1
leads to an increased translocation of GlcCer into the Golgi
lumen (Lala et al., 2000; Eckford and Sharom, 2005), raising
the supply of this lipid for the synthesis of other GSL,
including Gb3. We reasoned that the effect of inhibiting
Figure 4. NB-DGJ reduces the association of SLTx with cell surface
DRM. SLTx (1 M) was bound to control HeLa cells (A) or NB-DGJ
treated (2 h; 100 M) HeLa cells (B) on ice. The cells were washed
and mechanically lysed with the resulting PNS incubated with 1%
Tx-100. DRM were floated in OptiPrep step gradients. The gradients
were fractionated and the presence of bound SLTx was determined
by gel electrophoresis and Western blotting and quantified using
enhanced chemifluorescence. Gradients were also analyzed by dot-
blot for GM1 (DRM marker) and by gel electrophoresis and blotting
for a non-DRM marker, the transferrin receptor (TnF-R). Means of
three experiments (SEM) are shown.
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MDR-1 activity should therefore be similar to that seen for
NB-DGJ treatment. Indeed, when we examined the amount
of SLTx associated with DRM after a 2-h pretreatment of
HeLa cells with the well characterized MDR-1 inhibitor cy-
closporine A (CsA) (Lavie et al., 1997; Landwojtowicz et al.,
2002; Eckford and Sharom, 2005), it was found to be reduced
(Figure 6C) compared with control cells (Figure 4A). Fur-
thermore, when HeLa cells were pretreated with CsA (10
M; 2 h), they displayed appreciable resistance to a toxic
challenge with SLTx (Figure 6D). GSL analysis revealed that
treatment of HeLa cells with CsA (10 M; 2 h) reduced both
the total levels and DRM association of GlcCer (Table 5).
DRM-associated Gb3 was also reduced after CsA treatment,
but the total cellular pool remained unaffected (Table 5).
Interestingly, no protection from SLTx cytotoxicity was ob-
served in L3/bcl-2 cells treated with CsA (10 M; 2 h) (our
unpublished data), a finding that correlated well with the
unperturbed levels of GlcCer and Gb3 in these cells (Table 4).
Together, the data suggest that the degree of DRM associa-
tion of SLTx/Gb3 can be influenced by the levels of GlcCer.
SLTx Requires ER-DRM Association for Subsequent
Intoxication
Because the effect of NB-DGJ is to significantly mitigate
toxin potency, we propose that SLTx must require an inter-
action with DRM in the ER membrane for some crucial step
that is obligatory for toxin entry to the cytosol. Because SLTx
is thought to co-opt proteins involved in the retro-translo-
cation process associated with ER-associated degradation
(ERAD) (Ellgaard and Helenius, 2003; Helenius and Aebi,
2004), we isolated and analyzed DRM fractions for the pres-
ence of these proteins. A proportion of calnexin, ribo-
phorin-1, and Sec61 showed coincidence with the DRM
fraction in both control (Figure 7A) and NB-DGJ-treated
HeLa cells (Figure 7B), whereas this was not seen for PDI,
Derlin-1, or VIMP in either control (Figure 7C) or in NB-
DGJ-treated cells (Figure 7D). The fraction of Sec61 in DRM
Figure 5. NB-DGJ does not affect the cyto-
toxicity of SLTx in L3/bcl-2 cells that main-
tain Gb3 receptors in DRM. (A) L3/bcl-2 cells
were pretreated with either media (F) or 100
M NB-DGJ (E) for 2 h before incubation
with increasing concentrations of SLTx for
4 h at 37°C. Incorporation of [35S]methionine
was used to determine remaining cellular
protein synthesis, compared with untreated
cells. SEs were 10%. (B) Analysis of Gb3
association with DRM in L3/bcl-2 cells on
binding of SLTx. Ice-cold L3/bcl-2 control
cells or SLTx (1 M)-bound cells were
washed, mechanically lysed, DRM extracted
in 1% Tx-100 buffer, and floated in OptiPrep
step gradients. The gradients were fraction-
ated, and the neutral GSLs were extracted
and separated by TLC. The presence of Gb3
in the fractions was detected (top) and quan-
tified (graph) by overlay with SLTxB and
ECF. (C) SLTx (1 M) was bound to control
L3/bcl-2 cells or (D) to NB-DGJ-treated (2 h;
100 M) L3/bcl-2 cells on ice. The cells were
washed and mechanically lysed with the re-
sulting PNS incubated with 1% Tx-100. DRM
were floated in OptiPrep step gradients. The
gradients were fractionated, and the presence
of bound SLTx was determined by gel elec-
trophoresis and Western blotting and quan-
tified using enhanced chemifluorescence.
Gradients were also analyzed by dot-blot for
GM1 (DRM marker) and by gel electrophore-
sis and blotting for a nonraft marker, the
transferrin receptor (TnF-R). Means of three
experiments (SEM) are shown.
Table 4. GSL composition in L3/bcl-2 cells in the presence of
NB-DGJ
Total levels of GSL examineda
Control
NB-DGJ
(2 h)
NB-DGJ
(16 h)
CsA
(2 h)
Gb3 14.0  1.0 17.0 2.0 13 1 19  2
GlcCer 15.0 4.0 19.0 4.0 8 2 17  5
LacCer 3.0 1.0 3.0 1.0 4 1 3  1
GM3 13.0  1.0 14.0 1.0 18 1 14  1
Gb4 0.2  0.1 0.2 0.1 0.3 0.1 0.2 0.1
a Picomoles per microgram of protein (SE); n  3.
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(Figure 7) was similar to that previously visualized after
detergent extraction (Figure 3B). Recently, a subcompart-
ment of the ER has been identified in which a membrane-
bound ERAD substrate, the precursor of human asialogly-
coprotein receptor H2a, accumulated to be observed as
punctate structures within the ER upon inhibition of protea-
somes in the cytosol (Kamhi-Nesher et al., 2001). We there-
fore examined the distribution of Cy2-labeled SLTx internal-
ized for 4 h into HeLa cells after a 5-h inhibition of
proteasomes using 10 M MG132 (Figure 8). SLTx staining
revealed a general reticular pattern consistent with an ER
localization in untreated cells (Figure 8, left), whereas toxin
was observed to accumulate in punctate structures, re-
stricted to juxtanuclear and peripheral regions of ER in
MG132-treated cells (Figure 8, middle). This accumulation
was consistent with that seen for H2a under identical con-
ditions of proteosomal inhibition (Kamhi-Nesher et al.,
2001). This punctate staining of SLTx was lost after protea-
some inhibition and NB-DGJ treatment. Instead, a more
general ER reticular staining was revealed (Figure 8, right).
These data suggest that NB-DGJ treatment that reduces the
cellular level of GlcCer perturbs the ability of SLTx to local-
ize in areas of the ER that are compatible for subsequent
retro-translocation to the cytosol.
DISCUSSION
In this study, we have shown that specific inhibition of
ceramide glucosyltransferase with NB-DGJ (Platt et al., 1994)
completely protected both HeLa and Vero cells from subse-
quent intoxication by SLTx. Under the conditions used here,
treatment with NB-DGJ altered neither the binding affinity
of the toxin to its GSL receptor Gb3 nor the overall number
of receptors. Treatment did lower the recruitment of SLTx
into detergent resistant membranes at the cell surface, al-
though presumably, sufficient association remained to per-
mit retrograde transport to the ER (Falguieres et al., 2001;
Nichols et al., 2001; Rodighiero et al., 2001; Fujinaga et al.,
2003; Hoey et al., 2003; Lencer and Tsai, 2003). However,
NB-DGJ abolished DRM association of SLTx within the ER.
Because we interpret DRM to represent lipid microdomains
in the original membrane, we propose that the absence of
SLTx from such microdomains in the ER membrane is the
most likely explanation for the acquired resistance of NB-
DGJ-treated cells to this lipid-binding toxin.
A number of groups have now provided good evidence
for the existence of lipid rafts or microdomains in cell mem-
branes (Friedrichson and Kurzchalia, 1998; Harder et al.,
1998; Varma and Mayor, 1998; Pralle et al., 2000; Wilson et al.,
2000). The inclusion or exclusion of certain lipids and pro-
teins and the affinity of a given protein for such rafts can
result in a locally different character of the lipid microdo-
main compared with the surrounding membrane, giving
rise to a variety of different cellular functions (London and
Figure 6. The association of SLTx/Gb3 complexes with DRM is
influenced by other GSL. GM95 cells were incubated with 20 M
Gb3 for 48 h in the presence or absence of 20 M GlcSph. The cells
were washed, lysed in 0.5% Tx-100 buffer, and DRM were floated on
step gradients. The gradients were fractionated, and the levels of
Gb3 and GM3 in both the DRM fraction (A) and the total cellular
fraction (B) were quantified. (C) Cyclosporin A-treated (2 h; 10 M)
HeLa cells were incubated with 1 M SLTx for 30 min on ice. The
cells were washed, mechanically lysed, DRM extracted in 1% Tx-100
buffer, and floated in OptiPrep step gradients. The gradients were
fractionated, and the presence of bound SLTx was determined by
gel electrophoresis and Western blotting and quantified using en-
hanced chemifluorescence. Gradients were also analyzed by dot-
blot for GM1 (DRM marker) and by gel electrophoresis and blotting
for a non-DRM marker, the transferrin receptor (TnF-R). Means of
three experiments (SEM) are shown. (D) HeLa cells were pre-
treated with either media (F) or 10 M cyclosporin A (E) for 2 h
before incubation with increasing concentrations of SLTx for 4 h at
37°C. Incorporation of [35S]methionine was used to determine re-
maining cellular protein synthesis, compared with untreated cells.
SEs were 10%.
Table 5. GSL composition in HeLa cells in the presence of the
MDR-1 inhibitor cyclosporin A
Control CsA (2h)
Total levels of GSL examineda
Gb3 1.0  0.4 1.0  0.2
GlcCer 2.6 0.1b 0.6  0.2b
LacCer 1.0 0.5c 0.40  0.1c
GM3 1.0  0.3 0.40  0.1
nLc4 0.20  0.06 0.20 0.06
Sialyl-nLc4 0.4  0.1 0.60  0.20
Tx-100 resistant levels of GSL examined1
Gb3 71  8d 17  1d
GlcCer 101 3e 19  4e
LacCer 39 2 6  1
GM3 35  2 3  1
nLc4 13  1 4  1
Sialyl-nLc4 10  1 13  2
a Picomoles per microgram of protein (SE); n  3–7.
b Extremely statistically significant, two-tailed p value  0.0002.
c Not statistically significant, two-tailed p value  0.2288.
d Extremely statistically significant, two-tailed p value  0.0005.
e Extremely statistically significant, two-tailed p value  0.0001.
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Brown, 2000). Although lipid microdomains on the cell sur-
face tend to be transient (Schutz et al., 2000), relatively stable
microdomains have been visualized in the endocytic path-
way (Sharma et al., 2003) where they are proposed to play a
role in protein and lipid sorting (Gruenberg, 2001). Al-
though it is not possible to isolate lipid microdomains or
rafts in their native state, the dense packaging of GSL to
form liquid ordered (lo) phases in artificial membranes, and
by extension lo domains in cell membranes, gives rise to a
characteristic detergent resistance. This in turn allows for a
simple biochemical purification of DRM. These are generally
interpreted as representing lipid microdomains/rafts and as
such they have been used to indicate whether a particular
protein associates with lipid rafts in vivo (London and
Brown, 2000). However, the physical basis for the extraction
of lipids with detergents is poorly understood, and care
should be taken in experimental interpretation and any ex-
trapolation to their in vivo function. Furthermore, it is un-
likely that DRM isolated from cells accurately reflect preex-
isting structures or organization of the membrane. That said,
however, the ability to partition with the DRM fraction
could reflect an important membrane-related biochemical
property of the specific component in question.
We have shown that recruitment and partitioning of the
Gb3/SLTx complex to such DRM is influenced by the avail-
ability of GlcCer. Whereas the amount of DRM-associated
SLTx was reduced upon treatment of cells with either NB-
DGJ or cyclosporine A (an inhibitor of the GSL flippase,
MDR-1; De Rosa et al., 2004), it was increased by the addition
of exogenous glycosphingosine, a precursor of GlcCer. In-
deed, previous transfection of Madin-Darby canine kidney
(MDCK) cells with the gene for MDR-1, whose protein prod-
uct would increase the availability of GlcCer, dramatically
increased the sensitivity of these cells to the action of SLTx
(Lala et al., 2000). It has been reported that some types of
GSL are capable of modulating the association of specific
lipids and proteins within DRM. GlcCer depletion of RAW
macrophages increased the detergent resistance of the spe-
cific GSL, GD1a (Sillence et al., 2002). The association of Src
proteins with DRM in Lewis lung carcinoma cells was elim-
inated after depletion of GlcCer, LacCer, and GM3 (Inokuchi
et al., 2000). An in vitro study has also shown that in artificial
liposomes containing LacCer, GPI-anchored membrane
dipeptidase was sequestered into DRM. However, lipo-
somes alone, or liposomes enriched with different GSL,
failed to support DRM association of this protein (Parkin et
al., 2001). This type of modulation may also occur in the
opposite direction. For example, addition of GM1 to MDCK
cells rendered a GPI-anchored form of the growth hormone
decay accelerating factor protein that was originally deter-
gent resistant, now susceptible to detergent extraction (Si-
mons et al., 1999). It has been shown that preferential deple-
tion of GSL in DRM fractions does not affect the levels of
sphingomyelin or cholesterol and does not induce signifi-
Figure 7. A proportion of some ER-resident
proteins involved with ERAD and retro-
translocation are found in DRM. Untreated
HeLa cells (A and C) or NB-DGJ-treated (2 h;
100 M) HeLa cells (B and D) were washed,
lysed in 1% Tx-100 buffer, and DRM were
floated in OptiPrep step gradients. The gra-
dients were fractionated, and the location of
the various ER-resident proteins was deter-
mined by gel electrophoresis and Western
blotting with specific antisera. Gradients
were also analyzed by dot-blot for GM1
(DRM marker) and by gel electrophoresis
and blotting for a non-DRM marker, the
transferrin receptor (TnF-R). (E) Untreated.
(F) NB-DGJ-treated cells.
Figure 8. ER-localized SLTx accumulates at discrete locations upon inhibition of proteasomes. Cy2-coupled SLTx was bound to the plasma
membrane of control (left) or MG132 (10 M; 5 h)-treated (middle), or MG132- (10 M; 5 h) and NB-DGJ (100 M; 2 h)-treated (right) HeLa cells
on ice. The cells were washed and shifted to 37°C for 4 h. Cells were washed and placed on ice and then fixed and permeabilized. Cells were washed
and mounted and viewed by confocal microscopy.Arrowheads indicate the accumulation in punctate regions of the ER. Bar, 5 m.
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cant changes in the distribution of proteins (Shu et al., 2000).
Therefore, the role of GSL in affecting DRM association of
other constituents seems to be highly specific. How specific
GSL influence whether a particular lipid or protein is found
within a lipid microdomain remains unclear. It is interesting
to note that an ER monohexosylceramide flippase has been
identified (Buton et al., 2002). This may be effected either
directly or indirectly because GlcCer transferase inhibitors
can have more than one site of action (Kok et al., 1998).
Interestingly, the fatty acyl chain length of Gb3 can affect
the intracellular trafficking of STx/SLTx, with binding to the
shorter C16–C18 isoforms promoting transport to the ER
and enhancing cytotoxicity (Sandvig et al., 1994; Arab and
Lingwood, 1998). However, tight packing of GSL with long,
rather than short, acyl chains is a key feature of lipid mi-
crodomain organization (Brown and London 2000). It is
therefore reasonable to propose that the presence of GlcCer
can increase the affinity of the shorter Gb3 isoforms that
correlate with efficient ER routing and cytotoxicity of SLTx,
for DRM association. The data presented here are in agree-
ment with this hypothesis because the effects of inhibiting
GSL synthesis with NB-DGJ resulted in a reduction in the
amount of Gb3-bound SLTx recruited into DRM that corre-
lated with a lower level of GlcCer. It has been demonstrated
that association of raft components can be stabilized by
cross-linking (Harder et al., 1998). The receptor-binding
SLTx B chains are pentameric, and it is known from the
crystal structure that cross-linking of Gb3 molecules occurs
when this toxin binds to the lipid (Ling et al., 1998). How-
ever, our data suggest that Gb3 cross-linking alone is not
sufficient to promote the association of SLTx into triton-
extractable DRM, because the binding affinity of the toxin for
its receptor was unaltered after NB-DGJ treatment, even
though the amount found in DRM was reduced.
NB-DGJ treatment only lowered the DRM association of
SLTx at the plasma membrane and had no effect on retro-
grade transport to the ER. However, NB-DGJ abolished
toxin sequestration into DRM at the level of the ER and
completely protected cells from SLTx. This suggests that
DRM association of SLTx in the ER is an essential require-
ment for the subsequent intoxication of HeLa cells by SLTx.
The gradient in the observed amount of SLTx found with
DRM after drug treatment is consistent with the cis-Golgi
localization of ceramide glucosyltransferase. After a 2-h in-
hibition of GlcCer synthesis with NB-DGJ it might be ex-
pected that levels of GlcCer in the Golgi and ER be depleted
more quickly than at the plasma membrane.
To inactivate ribosomes, the catalytic A1 domain of SLTx
must first retrotranslocate across the ER membrane. Little is
known about the mechanistic aspects of this process, al-
though certain interactions have been demonstrated for the
related toxin CTx and for ricin. Within the ER, the catalytic
A-chains of both these toxins are liberated from their respec-
tive B-subunits by the action of PDI (Tsai et al., 2001; Spooner
et al., 2004). CTx-A is also unfolded by PDI before its retro-
translocation (Tsai et al., 2001; Tsai and Rapoport, 2002). The
unfolding of other toxins that reach the ER has not been
established. However, ricin A chain (RTA) and STx-A have
both been shown to interact with negatively charged phos-
pholipid vesicles (Suhan and Hovde, 1998; Day et al., 2002).
Indeed, RTA undergoes significant structural change upon
interacting with such lipids (Day et al., 2002), whereas mu-
tations in a proposed membrane-insertion domain of STx-A
reduced its interaction with lipids with a concomitant effect
on cytotoxicity (Suhan and Hovde, 1998; LaPointe et al.,
2005). Whether these events occur within the ER is un-
known, but it remains an appealing possibility that interac-
tions with lipids play an important role in preparing some
toxins for the ER membrane translocation step. The nega-
tively charged phospholipid phosphatidylserine (PS) is
present within both leaflets of the ER membrane of mam-
malian cells (Chang et al., 2004) and indeed can be highly
enriched within DRM (Pike et al., 2002). Furthermore, it has
been demonstrated that the presence of GlcCer dramatically
enhanced the interaction of activated protein C with nega-
tively charged PS vesicles (Yegneswaran et al., 2003), leading
to the hypothesis that microdomains enriched in neutral
GSL can promote specific phospholipid–protein interac-
tions. Our data are clearly consistent with this. After NB-
DGJ treatment, when the overall level of GlcCer is reduced,
SLTx in the ER is absent from isolated DRM. As such, after
subunit reduction in the ER lumen, we propose that the
SLTx A-chain may not be correctly positioned to interact
with negatively charged lipids either because of its nonraft
location and/or the absence of GlcCer.
It is widely held that toxin retro-translocation to the cy-
tosol is mediated by the machinery used to discharge newly
made but misfolded or orphan proteins to the cytosol for
destruction by proteasomes (Simpson et al., 1999; Wesche et
al., 1999; Teter et al., 2002, 2003), in the process of ERAD.
Lipid-induced changes in the secondary and tertiary struc-
ture of RTA have been demonstrated previously (Day et al.,
2002), leading to the proposition that this might allow inter-
ception by ERAD proteins to trigger toxin retro-transloca-
tion. A similar situation may apply to SLTx/STx, although
this is currently unclear. A novel quality control subcom-
partment of the ER for membrane-bound ERAD substrates
has been identified in mammalian cells (Kamhi-Nesher et al.,
2001). On perturbation of the cytosolic degradation machin-
ery, an H2a ERAD substrate accumulated in cells alongside
the ER chaperones calreticulin and calnexin (but not PDI),
and was visualized by a punctate juxtanuclear staining of
the ER. Pulse–chase analysis and coimmunoprecipition after
the synthesis of the mutant H2a revealed an increased in-
teraction between mutant H2a and Sec61-, whereas total
H2a levels decreased because of proteosomal degradation. It
was therefore suggested that interaction with Sec61 could be
the rate-limiting step during retro-translocation of ERAD
substrates (Kamhi-Nesher et al., 2001). Our data show that
SLTx internalized into HeLa cells gives a similar punctate
juxtanuclear ER staining upon inhibition of proteasomes but
not when GlcCer is depleted. Furthermore, we found ribo-
phorin, calnexin and Sec61- but not PDI, Derlin-1 or VIMP
to be DRM-associated in HeLa cells. Recently, it has been
shown that SLTx can interact with a range of ER proteins,
including BiP, calnexin, and Sec61, required for transport
from the ER lumen to the cytosol (Yu and Haslam, 2005).
Although detergent extraction has been widely used to
postulate in vivo lipid microdomain association, a degree of
caution must be taken when relating this to lipid rafts within
the ER. However, the use of such methodology to study
ER-resident proteins within DRM has been demonstrated
previously (Sevlever et al., 1999; Falguieres et al., 2001; Li et
al., 2003; Falguieres and Johannes, 2006). Indeed, it has been
proposed that because of the lower content of cholesterol
and GSL in the ER membrane, weaker interactions may
result between ER–DRM components, such that extraction
with 1% Tx-100 may actually result in an underestimation of
the association of some ER components with DRM (Sevlever
et al., 1999). We therefore feel that our data showing DRM
association of certain ER-resident proteins, with the exclu-
sion of others, is not artificial and could correlate with a
proportion of these being partly present within liquid-or-
dered microdomains in the ER membrane. Indeed, the ER-
D. C. Smith et al.
Molecular Biology of the Cell1384
resident proteins calnexin (Sevlever et al., 1999; Li et al., 2003)
and BiP (Falguieres et al., 2001; Falguieres and Johannes,
2006) have previously been isolated in DRM. However, our
finding of Sec61- within a DRM fraction contradicts a pre-
vious report of a study in yeast, where the homologue
Sec61p was soluble in cold Tx-100 (Bagnat et al., 2000). This
might reflect differences between the sterol-mediated ER
microdomain organization of yeast and mammalian systems
(Arora et al., 2004) and/or their ERAD mechanisms, such as
the apparent lack of a calnexin–calreticulin cycle in yeast
(Mancini et al., 2003; Helenius and Aebi, 2004). Other mem-
brane complexes, Derlin-1 and VIMP, have recently been
identified as being important for the retro-translocation of
major histocompatability complex (MHC) class I molecules
mediated by the human cytomegalovirus-encoded glyco-
protein US11 (Lilley and Ploegh, 2004; Ye et al., 2004). Here,
we show these proteins cannot be extracted within DRM. As
yet, no role for the Derlin-1-containing complex in the dis-
location of ER-directed toxins has been established. Further-
more, this complex seems substrate-specific because the dis-
location of MHC class I molecules catalyzed by the related
human cytomegalovirus-encoded glycoprotein US2 is inde-
pendent of Derlin-1 (Lilley and Ploegh, 2004).
In conclusion, our study has revealed the importance of
GlcCer levels in determining the fraction of SLTx/Gb3 com-
plexes found within DRM. This interaction with Gb3 recep-
tors in DRM seems critical not only for transport to the ER
but also for a later step at the level of the ER. It is possible
that the association with DRM may influence toxin retro-
translocation to the cytosol. Further work is now required to
identify the precise molecular composition of ER membrane
microdomains and the role(s) these play in facilitating trans-
port of this toxin to the cytosol.
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